Expert Market Research provides a comprehensive overview of the ongoing efforts in drug development for X-linked adrenoleukodystrophy (X-ALD), a rare but severe genetic disorder. X-ALD is recognized as the most prevalent peroxisomal disorder, primarily affecting the adrenal cortex and central nervous system. With an incidence of approximately 1 in 14,000 to 1 in 17,000 male births, X-ALD has...